Tobin W Juvenal Castle Biosciences Inc (CSTL) insider trading activity

Tobin W Juvenal is Chief Commercial Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 69,943 shares of CSTL, which is worth approximately $1.97 Million. The most recent transaction as insider was on Jan 06, 2025, when has been sold 2,230 shares (Common Stock) at a price of $30.0 per share, resulting in proceeds of $66,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.9K

24.5% 3M change

49.27% 12M change

Total Value Held $1.97 Million

Tobin W Juvenal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2025	SELL Open market or private sale	$66,900 $30.0 p/Share	2,230 Reduced 3.09%	69,943 Common Stock
Dec 10 2024	SELL Payment of exercise price or tax liability	$59,200 $29.63 p/Share	1,998 Reduced 2.69%	72,173 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	7,919 Added 9.71%	73,676 Common Stock
Dec 09 2024	SELL Payment of exercise price or tax liability	$120,147 $30.91 p/Share	3,887 Reduced 5.54%	66,252 Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	-	15,961 Added 18.54%	70,139 Common Stock
Nov 05 2024	SELL Open market or private sale	$124,708 $35.56 p/Share	3,507 Reduced 6.08%	54,178 Common Stock
Nov 05 2024	BUY Exercise of conversion of derivative security	$11,853 $3.38 p/Share	3,507 Added 5.73%	57,685 Common Stock
Nov 01 2024	SELL Open market or private sale	$109,709 $35.39 p/Share	3,100 Reduced 5.41%	54,178 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$3,718 $3.38 p/Share	1,100 Added 1.88%	57,278 Common Stock
Aug 09 2024	SELL Payment of exercise price or tax liability	$69,543 $26.83 p/Share	2,592 Reduced 4.41%	56,178 Common Stock
Aug 09 2024	BUY Grant, award, or other acquisition	-	10,641 Added 15.33%	58,770 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$19,365 $2.89 p/Share	6,701 Added 12.51%	46,857 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$38,928 $20.17 p/Share	1,930 Reduced 4.59%	40,156 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	7,920 Added 16.33%	40,583 Common Stock
Dec 09 2023	SELL Payment of exercise price or tax liability	$78,400 $20.17 p/Share	3,887 Reduced 10.21%	34,166 Common Stock
Dec 09 2023	BUY Exercise of conversion of derivative security	-	15,961 Added 29.55%	38,053 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	$14,753 $2.39 p/Share	6,173 Added 21.84%	22,092 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$43,077 $22.32 p/Share	1,930 Reduced 11.37%	15,039 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	7,920 Added 32.38%	16,542 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	$8,806 $2.38 p/Share	3,700 Added 29.02%	9,049 Common Stock
Dec 10 2021	SELL Payment of exercise price or tax liability	$17,302 $40.52 p/Share	427 Reduced 8.08%	4,855 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	-	1,750 Added 24.89%	5,282 Common Stock
Jun 17 2021	SELL Open market or private sale	$754,000 $75.4 p/Share	10,000 Reduced 77.96%	2,827 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$23,800 $2.38 p/Share	10,000 Added 43.81%	12,827 Common Stock

TWJ

Tobin W Juvenal

Chief Commercial Officer

Friendswood, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Value

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL

Account